A multifaceted intervention to improve patient knowledge and safe use of opioids: Results of the ED EMC2 randomized controlled trial
Academic Emergency Medicine Nov 24, 2019
McCarthy DM, Curtis LM, Courtney DM, et al. - Researchers examined how an Electronic Medication Complete Communication (EMC2) Opioid Strategy affects patients’ safe use of opioids and knowledge about opioids. In this three-arm randomized controlled pragmatic trial, they randomized 652 consecutive discharged patients at an urban academic emergency department (ED) (> 88,000 visits) with new hydrocodone-acetaminophen prescriptions to receive one of three care pathways: 1) usual care, 2) EMC2 intervention or 3) EMC2 + short message service (SMS) text messaging. Of these, 343 completed follow-up (57% women; mean ± SD age = 42 ± 14.0 years). The analysis revealed that safe dosing improved with the EMC2 tools, however, these benefits did not translate into actual use based on medication dairies. No improvement in patient knowledge was observed with the text-messaging intervention.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries